Tamoxifen in the treatment of infertile patients associated with inadequate luteal phase

tamoxifen treatment luteal phase deficiency infertility, inadequate luteal phase tamoxifen ovulation induction, selective estrogen receptor modulator luteal phase defect, tamoxifen infertility treatment hormonal therapy, luteal phase insufficiency anti-estrogen treatment, tamoxifen versus clomiphene luteal phase support, ovulation induction tamoxifen luteal phase inadequacy, tamoxifen progesterone luteal support infertile women, Tajima tamoxifen luteal phase infertility, anti-estrogen therapy female infertility ovulatory dysfunction

PMID 6421628 6421628 DOI 10.1016/s0015-0282(16)47730-7 10.1016/s0015-0282(16)47730-7